Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by SouthernTierTomon Aug 10, 2021 12:59pm
1876 Views
Post# 33678730

6 months or 11 years? Kellum has been around 4ever!

6 months or 11 years? Kellum has been around 4ever!NOT too much has changed with PMX or the EAA over the last 20 years.  Dr. Kellum served as the lead on the "data safety monitoring board" or DSMB as part of the phase 3 Euphrates trial from 2010 to 2016..."HE has SEEN IT ALL"!

Unless he needs new corrective lens to see the data more clearly, I would suggest he has "seen all he needs to see" ...despite being told that phase 3B/4 confirmatory trials in a critical care setting with a 2 to 1 ratio in favor of the "proposed treatment" by an experienced and VERY well seasoned EDT board memeber ( now retired ) was, "NO BIG DEAL, and quite common", I disagree and search for a comparative...Hmmmm??

Kellum has been part of this story for well over 10 years and perhaps longer, WE are all just delighted that the 56 second video on the size of the "magic beads" is NO longer a focus and bringing this medical device that Baxter felt worthy of handing us $6.6M CAD for ( just to be the lead sales option, "NO RIGHTS" ) is now the "soup du jour" ( that is french ).

I call your attention to today's curious SIGY NR and their reference to CTSO..Hmmmm..I've had a recent chat with the SIGY boss and he is well aware of EDTXF...he also suggested that BIG FARMA would need to take an interest in "filtration"...I thought Baxter was BIG..until we split them into 108 tiny pieces of insignificant monetary units...; - )

More from me later, sore throat and down for the count..I will provide more meaningful "color" later...NOTE; I spell color properly!
<< Previous
Bullboard Posts
Next >>